FIELD: chemistry.
SUBSTANCE: invention relates to biologically active cation alkyl-type glycerolipid containing a fluorescent tag in its structure, and more specifically to Rac-N,N-dimethyl-N-[2-(5-N',N'-dimethylaminonaphthalene-1-sulfonyloxy)ethyl]-N-{4-[(2-methoxy-3-octadecyloxy)prop-1-yloxycarbonyl]butyl}ammonium iodide.
EFFECT: obtaining a novel compound which can be used in medicine as an anti-tumour agent.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOPHILIC POLYAMINES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2618393C1 |
| APPLICATION OF RAC-N-{4-[(2-ETHOXY-3-OCTADECYLOXY)PROPYL] OXYCARBONYLBUTYL}-N-METHYL-IMIDAZOLINE IODIDE AS A MULTIKINASE INHIBITOR | 2015 |
|
RU2625749C2 |
| 1-HEXADECYL-5-(1-PYRENEBUTYL)-N-(L-ORNITILE)-L-GLUTAMATE BISCHLORIDE | 2009 |
|
RU2409587C2 |
| N-(2-(2-(2-AZIDOETHOXY)ETHOXY)ETHYL)-4,6-DI(AZIRIDIN-1-YL)-1,3,5-TRIAZIN-2-AMINE, HAVING CYTOTOXIC ACTION | 2023 |
|
RU2825828C1 |
| PHENOTHIAZINE-CONTAINING 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE DERIVATIVES AS AGENT FOR REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM, METHODS FOR PRODUCTION THEREOF, PHARMACOLOGICAL AGENT BASED THEREON AND METHOD OF REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM | 2013 |
|
RU2529899C1 |
| 1-SULFONYL-2-(DIPHENYLPHOSPHORYL)PYRROLIDINES HAVING CYTOTOXICITY AGAINST CERVICAL CANCER CELLS, AND A METHOD OF PRODUCING SAID | 2020 |
|
RU2736205C1 |
| N-ACYLIC DERIVATIVES OF 1-METHYLAMINO-1-DESOXYPOLYOLES MANIFESTING ANTITUMOR ACTIVITY | 0 |
|
SU677290A1 |
| N-2@-AMINOBENZYLIDENE-(1)-2-(5-ALKYLISOTHIOSEMICARBAZONOMETHYL)-(1) -ANILINE-N,N,N,N-NICKEL | 0 |
|
SU1708813A1 |
| N,N'((ALKANDIYL)BIS[LABDA-7(9),13,14-TRIENE-4-CARBOXAMIDES] WITH ANTITUMOUR ACTIVITY | 2017 |
|
RU2654201C1 |
| N-NITROSO-N-[(2-CHLOROETHYL)CARBAMOYL]-L- ORNITHINE | 2012 |
|
RU2503657C1 |
